How many clinical trials are tracked for Cardiac Allograft Vasculopathy?

5 trials are tracked, 1 with published results.

Mode

All Oncology Infectious Disease Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Anesthesiology & Pain Medicine Genetics & Precision Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Urology Emergency Medicine Ophthalmology Hematology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Cardiac Allograft Vasculopathy

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Cardiac Allograft Vasculopathy

5 trials tracked for Cardiac Allograft Vasculopathy: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 76 citations.

5Trials tracked

3Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 4 2 Phase 3 1 Phase 2 1 Other / NA 1

Phase 3 The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation Completed · 76 cited
Phase 4 Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy Completed
Phase 4 Endothelin-1 and Cardiac Allograft Vasculopathy (CAV) Completed
Phase 2 Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation Completed
N/A Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.